Klaus Faßbender

Short chain fatty acids and gut microbiota differ between patients with Parkinson's disease and age-matched controls

Marcus M. Unger, Jörg Spiegel, Klaus-Ulrich Dillmann et al. · Parkinsonism & Related Disorders · 2016 · 1.1K citations

Obesity, Nutrition, Dysbiosis +12

Role of the Toll-Like Receptor 4 in Neuroinflammation in Alzheimer’s Disease

Silke Walter, Maryse Letièmbre, Yang Liu et al. · Cellular Physiology and Biochemistry · 2007 · 511 citations

Tlr4 Mrna, Innate Immune System, Immunology +18

Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial

Silke Walter, Panagiotis Kostopoulos, Isabel Keller et al. · The Lancet Neurology · 2012 · 484 citations

Thrombosis, Stroke Rehabilitation, Cardiovascular Disease +12

TLR2 Is a Primary Receptor for Alzheimer’s Amyloid β Peptide To Trigger Neuroinflammatory Activation

Shirong Liu, Yang Liu, Wenlin Hao et al. · The Journal of Immunology · 2011 · 425 citations

Immunology, Neurochemical Biomarkers, Peptide Science +27

LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide

Yang Liu, Silke Walter, Massimiliano Stagi et al. · Brain · 2005 · 345 citations · Full text